Leukotriene receptor antagonist-associated Churg–Strauss syndrome
Leukotriene receptor antagonist-associated Churg–Strauss syndrome may occur in asthma patients being treated with leukotriene receptor antagonists, occurring 2 days to 10 months after the antagonist has been started, with features of the syndrome including peripheral eosinophilia, pulmonary infiltrates, and less commonly neuropathy, sinusitis, and cardiomyopathy.[1]:135–6
| Leukotriene receptor antagonist-associated Churg–Strauss syndrome |
|---|
See also
- Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)
- Leukotriene antagonist
- Skin lesion
References
- James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. ISBN 0-7216-2921-0.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.